These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 29961848)

  • 1. Community-based Malaria Screening and Treatment for Pregnant Women Receiving Standard Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: A Multicenter (The Gambia, Burkina Faso, and Benin) Cluster-randomized Controlled Trial.
    COSMIC Consortium
    Clin Infect Dis; 2019 Feb; 68(4):586-596. PubMed ID: 29961848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community-based scheduled screening and treatment of malaria in pregnancy for improved maternal and infant health in The Gambia, Burkina Faso and Benin: study protocol for a randomized controlled trial.
    Scott S; Mens PF; Tinto H; Nahum A; Ruizendaal E; Pagnoni F; Grietens KP; Kendall L; Bojang K; Schallig H; D'Alessandro U
    Trials; 2014 Aug; 15():340. PubMed ID: 25169073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Non-Inferiority, Individually Randomized Trial of Intermittent Screening and Treatment versus Intermittent Preventive Treatment in the Control of Malaria in Pregnancy.
    Tagbor H; Cairns M; Bojang K; Coulibaly SO; Kayentao K; Williams J; Abubakar I; Akor F; Mohammed K; Bationo R; Dabira E; Soulama A; Djimdé M; Guirou E; Awine T; Quaye S; Njie F; Ordi J; Doumbo O; Hodgson A; Oduro A; Meshnick S; Taylor S; Magnussen P; ter Kuile F; Woukeu A; Milligan P; Chandramohan D; Greenwood B
    PLoS One; 2015; 10(8):e0132247. PubMed ID: 26258474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing the uptake of Intermittent Preventive Treatment of malaria in pregnancy using Sulfadoxine-Pyrimethamine (IPTp-SP) through seasonal malaria chemoprevention channel delivery: protocol of a multicenter cluster randomized implementation trial in Mali and Burkina Faso.
    Koita K; Bognini JD; Agboraw E; Dembélé M; Yabré S; Bihoun B; Coulibaly O; Niangaly H; N'Takpé JB; Lesosky M; Scaramuzzi D; Worrall E; Hill J; Briand V; Tinto H; Kayentao K
    BMC Public Health; 2024 Jan; 24(1):43. PubMed ID: 38166711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent screening and treatment with artemether-lumefantrine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria.
    Esu E; Berens-Riha N; Pritsch M; Nwachuku N; Loescher T; Meremikwu M
    Malar J; 2018 Jul; 17(1):251. PubMed ID: 29976228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A community effectiveness trial of strategies promoting intermittent preventive treatment with sulphadoxine-pyrimethamine in pregnant women in rural Burkina Faso.
    Gies S; Coulibaly SO; Ouattara FT; Ky C; Brabin BJ; D'Alessandro U
    Malar J; 2008 Sep; 7():180. PubMed ID: 18801158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and factors associated with carriage of Pfmdr1 polymorphisms among pregnant women receiving intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) and artemether-lumefantrine for malaria treatment in Burkina Faso.
    Natama HM; Toussaint R; Bazié DLC; Samadoulougou S; Coulibaly-Traoré M; Tinto H; Kirakoya-Samadoulougou F
    Malar J; 2020 Nov; 19(1):399. PubMed ID: 33172485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mefloquine for preventing malaria in pregnant women.
    González R; Pons-Duran C; Piqueras M; Aponte JJ; Ter Kuile FO; Menéndez C
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD011444. PubMed ID: 30480761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mefloquine for preventing malaria in pregnant women.
    González R; Pons-Duran C; Piqueras M; Aponte JJ; Ter Kuile FO; Menéndez C
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011444. PubMed ID: 29561063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cluster randomized trial of delivery of intermittent preventive treatment of malaria in pregnancy at the community level in Burkina Faso.
    Gutman JR; Stephens DK; Tiendrebeogo J; Badolo O; Dodo M; Burke D; Williamson J; Vibbert K; Youll SJ; Savadogo Y; Brieger WR
    Malar J; 2020 Aug; 19(1):282. PubMed ID: 32758233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additional Screening and Treatment of Malaria During Pregnancy Provides Further Protection Against Malaria and Nonmalarial Fevers During the First Year of Life.
    Natama HM; Rovira-Vallbona E; Sorgho H; Somé MA; Traoré-Coulibaly M; Scott S; Zango SH; Sawadogo O; Zongo SC; Valéa I; Mens PF; Schallig HDFH; Kestens L; Tinto H; Rosanas-Urgell A
    J Infect Dis; 2018 May; 217(12):1967-1976. PubMed ID: 29659897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malaria prevention during pregnancy: assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupela District, Burkina Faso.
    Sirima SB; Cotte AH; Konaté A; Moran AC; Asamoa K; Bougouma EC; Diarra A; Ouédraogo A; Parise ME; Newman RD
    Am J Trop Med Hyg; 2006 Aug; 75(2):205-11. PubMed ID: 16896120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent uptake of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine is associated with increased prevalence of Pfdhfr mutations in Bobo-Dioulasso, Burkina Faso.
    Cisse M; Awandare GA; Soulama A; Tinto H; Hayette MP; Guiguemdé RT
    Malar J; 2017 Jan; 16(1):38. PubMed ID: 28114990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individual efficacy of intermittent preventive treatment with sulfadoxine-pyrimethamine in primi- and secundigravidae in rural Burkina Faso: impact on parasitaemia, anaemia and birth weight.
    Gies S; Coulibaly SO; Ouattara FT; D'Alessandro U
    Trop Med Int Health; 2009 Feb; 14(2):174-82. PubMed ID: 19171009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community-based promotional campaign to improve uptake of intermittent preventive antimalarial treatment in pregnancy in Burkina Faso.
    Gies S; Coulibaly SO; Ky C; Ouattara FT; Brabin BJ; D'Alessandro U
    Am J Trop Med Hyg; 2009 Mar; 80(3):460-9. PubMed ID: 19270299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in the prevalence of mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates collected from early to late pregnancy in Nanoro, Burkina Faso.
    Ruizendaal E; Tahita MC; Geskus RB; Versteeg I; Scott S; d'Alessandro U; Lompo P; Derra K; Traore-Coulibaly M; de Jong MD; Schallig HDFH; Tinto H; Mens PF
    Malar J; 2017 Apr; 16(1):179. PubMed ID: 28454537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine during pregnancy in Burkina Faso: effect of adding a third dose to the standard two-dose regimen on low birth weight, anaemia and pregnancy outcomes.
    Valea I; Tinto H; Drabo MK; Huybregts L; Henry MC; Roberfroid D; Guiguemde RT; Kolsteren P; D'Alessandro U;
    Malar J; 2010 Nov; 9():324. PubMed ID: 24576068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placental malaria and low birth weight in pregnant women living in a rural area of Burkina Faso following the use of three preventive treatment regimens.
    Tiono AB; Ouedraogo A; Bougouma EC; Diarra A; Konaté AT; Nébié I; Sirima SB
    Malar J; 2009 Oct; 8():224. PubMed ID: 19811649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on maternal and birth outcomes in Machinga district, Malawi.
    Gutman J; Mwandama D; Wiegand RE; Ali D; Mathanga DP; Skarbinski J
    J Infect Dis; 2013 Sep; 208(6):907-16. PubMed ID: 23801600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.